1. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial;Group, A.I.M.S.Trial Study;Lancet,1988
2. Pre-admission recombinant tissue plasminogen activator (abstr);McNeill, A.; Cunningham, S.; Flannery, D.; Dalzell, G.; Wilson, C.; Tsoi, E.;Eur Heart J,1988
3. Prevention of myocardial damage in acute myocardial ischaemia by early treatment with intravenous streptokinase;Koren, G.; Weiss, A.T.; Hasin, Y.; Appelbaum, D.; Welber, S.; Rozenman, Y.;N Engl J Med,1985
4. for the European Study Group for recombinant tissue type plasminogen activator. BMJ';de Werf F, Van; AER, Arnold,1988
5. Patient and general practitioner delays in acute myocardial infarction;Rawles, J.M.; Haites, N.E.;BMJ,1988